Search | Cost Sharing | Search Results

August 21, 2020 Issue Brief

Contraception X Article: Out-of-Pocket Spending for Oral Contraceptives Among Women with Private Insurance Coverage After the Affordable Care Act

In an article for Contraception X, KFF’s Brittni Frederiksen, Matthew Rae, and Alina Salganicoff examine large employer plans to identify which types and brands of oral contraceptive pills have the largest shares of oral contraceptive users with out-of-pocket spending and which oral contraceptives have the highest average annual out-of-pocket costs after the ACA covered contraception under it’s preventive services provisions.

August 20, 2020 News Release

Analysis: Many Private Insurers Offer Financial Relief for COVID-19 Treatment, but Cost-Sharing Waivers Are Expiring

A new analysis finds that most people with individual or fully-insured group market coverage are in plans that waived cost-sharing for COVID-19 treatment, though many of those waivers are set to expire in the coming months. About 88% – nearly nine in ten – enrollees in the individual and fully-insured…

August 10, 2020 Issue Brief

Health Affairs Article: Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available

In an article in Health Affairs, KFF’s Juliette Cubanski, Sarah True and Tricia Neuman, and several other co-authors, explore how often brand-name drugs receive favorable formulary inclusion relative to generics in the Medicare Part D program’s prescription drug plans.

July 15, 2020 Issue Brief

COVID-19 Test Prices and Payment Policy

This analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal law now requires private insurers to cover COVID-19 tests at no cost to the patient and provides funding for people without health insurance.

June 4, 2020 Issue Brief

Insulin Costs and Coverage in Medicare Part D

In light of heightened attention to insulin and the Trump Administration’s new Part D model to address out-of-pocket costs for insulin for Medicare beneficiaries, we analyzed out-of-pocket spending on insulin by beneficiaries enrolled in Part D drug plans, variation in Part D plan formulary coverage and tier placement of insulin products, and trends in prices for insulin.

May 26, 2020 Issue Brief

Five Things to Know about the Cost of COVID-19 Testing and Treatment

This brief answer key questions on affordability of COVID-19 testing and treatment for people who are uninsured and those insured through private coverage, Medicare, and Medicaid.

May 6, 2020 Quiz

COVID-19 Quiz

This 10-question quiz tests your knowledge about the coronavirus and COVID-19, including issues around symptoms, testing, number of cases and deaths, and cost sharing for treatment.

May 5, 2020 Issue Brief

FAQs on Medicare Coverage and Costs Related to COVID-19 Testing and Treatment

These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries.

March 26, 2020 Report

Annual Updates on Eligibility Rules, Enrollment and Renewal Procedures, and Cost-Sharing Practices in Medicaid and CHIP

Since 2000, the Kaiser Family Foundation’s Program on Medicaid and the Uninsured has issued regular updates examining changes and trends in the eligibility rules, enrollment and renewal procedures and cost-sharing practices in Medicaid and CHIP. Those reports are compiled here.

March 24, 2020 Issue Brief

How Much Could Medicare Beneficiaries Pay For a Hospital Stay Related to COVID-19?

As the coronavirus continues to spread, the number of people on Medicare admitted to the hospital for COVID-19 related illness is expected to rise. We analyze how much Medicare beneficiaries could pay out-of-pocket for an inpatient hospital admission under traditional Medicare (assuming no supplemental coverage) or Medicare Advantage plans.

Refine Results

date

Topics

Content Type

Tags